GlassScriptPhysician profile
Robert A Moulton
NPI 1821072216
$2,969.20
in general payments reported to CMS, 2019-2025
21 companies · $372 in 2025
The $372 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $405 · 2020: $51.89 · 2021: $397 · 2022: $1,581 · 2023: $15.79 · 2024: $146 · 2025: $372.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $534.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $534.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Momentis Surgical INC. | $1,581.00 | 2022 | |
| Intuitive Surgical, INC. | $408.45 | 2020-2021 | |
| Shield Therapeutics INC | $268.56 | 2025 | |
| Merck Sharp & Dohme LLC | $140.12 | 2019-2020 | |
| Abbvie INC. | $101.53 | 2019 | |
| Sumitomo Pharma America, INC. | $86.48 | 2024-2025 | Myfembree |
| Coopersurgical, INC. | $52.49 | 2019-2025 | Paragard T 380a, Fisherbrand Disposable Liquid Infant Heel Warmer |
| Pfizer INC. | $46.63 | 2019-2024 | |
| Organon LLC | $46.22 | 2024-2025 | Nexplanon |
| Astellas Pharma US INC | $42.48 | 2019-2025 | Veozah |
| Therapeuticsmd, INC. | $23.68 | 2019-2020 | |
| Olympus America INC. | $23.63 | 2019 | |
| Mayne Pharma Commercial LLC | $21.83 | 2024-2025 | |
| Daiichi Sankyo INC. | $18.55 | 2019 | |
| Roche Diagnostics Corporation | $17.70 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $16.67 | 2020 | |
| Ethicon US, LLC | $15.79 | 2023 | Stratafix, Dermabond Prineo |
| Allergan, INC. | $15.55 | 2019 | |
| Exeltis, USA INC. | $15.25 | 2025 | Slynd |
| Duchesnay USA Incorporated | $13.52 | 2019 | |
| Boston Scientific Corporation | $13.07 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Moulton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.